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| INTRODUC TI ON
Alcohol consumption is a major risk factor for the development of upper aerodigestive tract cancers and also serves as a risk factor for the development of other cancers including hepatic, colorectal, breast and pancreatic cancer (Hsu et al., 2014; Latino-Martel et al., 2011; Pelucchi, Tramacere, Boffetta, Negri, & Vecchia, 2011) . Based on recent epidemiological studies, alcohol is estimated to be responsible for up to 3%-4% of all US cancer deaths; daily consumption of up to 20 g of alcohol (regardless of source) accounted for 26%-35% of alcohol-attributable cancer deaths (Nelson et al., 2013) . Up to 54% of head and neck cancer patients continue to consume alcohol after cancer diagnosis (Duffy et al., 2007 (Duffy et al., , 2002 .
Continued and especially excessive drinking after a cancer diagnosis may lead to worse patient outcomes including decreased rates of remission/overall survival, increased cancer recurrence and risk of second primary cancers, specifically in liver, upper aerodigestive tract and breast cancers, while evidence in other cancer subtypes is unclear (Druesne-Pecollo et al., 2014; Evangelista, Sarna, Brecht, Padilla, & Chen, 2003; Krebs et al., 2012; Li, Daling, Porter, Tang, & Malone, 2009; Mayne, Cartmel, Kirsh, & Goodwin, 2009; Thrift et al., 2012) . The effect of alcohol on quality of life outcomes in cancer survivors is also less clear, as studies have demonstrated mixed results (Allison, 2002; Duffy et al., 2002; Evangelista et al., 2003) . In addition to these cancer-related outcomes, health outcome risks associated with excessive alcohol consumption in the general patient population include addiction, hypertension, cerebrovascular disease, liver disease, accidents and social harms (Stockwell, Butt, Beirness, Gliksman, & Paradis, 2012) . With improvements in early detection and effective treatments, cancer survival has significantly improved, leading to a new focus on the long-term management of survivors.
However, guidelines for alcohol moderation have not been clearly defined for all types of cancer survivors, though guidelines are currently being developed for prostate cancer survivors (Skolarus et al., 2014) .
Although studies have explored factors influencing changes in other behaviours after a cancer diagnosis, there has been a paucity of studies investigating factors influencing alcohol moderation (either reduction or total cessation) among cancer survivors (Miller, Day, & Ravenel, 2006) . Based on the Health Belief Model (HBM), cancer diagnosis might be a teachable moment when patients may be willing to change their behaviours (Demark-Wahnefried, Aziz, Rowland, & Pinto, 2005; Rosenstock, Strecher, & Becker, 1988) . However, alcohol may be used as a coping mechanism to alleviate the anxiety and fear surrounding a cancer diagnosis and given its addictive nature, may result in sustained, increased or resumed consumption after a short period of abstinence. From the limited studies to date, gender, education, time since treatment, disease severity and heavier/ longer drinking have been identified as predictors of change in alcohol consumption in cancer patients (Allison, 2001; Christensen et al., 1999; Gritz et al., 1999; Miller et al., 2006) . Factors influencing alcohol consumption patterns in non-cancer populations include socio-demographics, other alcohol-related co-morbidities, use of other substances (i.e., smoking, marijuana) and outcome expectancies both from continued drinking and from moderation (Drumright et al., 2011; Kitsantas, Gaffney, Wu, & Kastello, 2014; Metrik, McCarthy, Frissell, MacPherson, & Brown, 2004) . However, none of these studies explicitly used the HBM framework in their analyses.
In the HBM, patients are willing to adopt health behaviour changes if (a) there is sufficient motivation, (b) patients have a perceived threat of sequelae, and (c) patients believe that health recommendations given can prevent or reduce that threat. With the diagnosis of cancer as the motivational teachable moment, we assessed patient perceptions and healthcare recommendations on moderating alcohol use that can reduce long-term harm. Our overall objective was to identify factors associated with alcohol moderation among cancer survivors and in particular those patients whereby alcohol is considered excessive according to gender-specific guidelines (Bondy et al., 1999) .
| MATERIAL S AND ME THODS

| Patient recruitment
Cancer patients were recruited in-person from ambulatory cancer care clinics from April to September 2012 at a tertiary cancer centre, Princess Margaret Cancer Centre, Toronto, Canada. The institutional research ethics board approved the study. Patients aged 18 years or older with a histological confirmation of any cancer of all stages were included. Patients with cognitive deficits or language barriers, patients perceiving themselves to be terminal/receiving end-of-life care at diagnosis and patients with <1 year of follow-up were excluded. Patients were approached in ambulatory cancer clinics by trained research assistants in a weekly rotating sequential fashion among different cancer disease sites. The clinics recruited from included breast, lung, gastrointestinal, genitourinary, gynaecological, head and neck, haematological, and skin/sarcoma clinics.
| Data collection and measurements
Upon recruitment, patients completed a single one-time cross-sectional self-administered questionnaire assessing: their alcohol consumption history at diagnosis and at one year following diagnosis; their current perceptions on the impact of alcohol consumption on quality of life, fatigue and overall survival at 5 years for their own specific circumstances and in the general cancer patient; whether they received information/guidance from healthcare providers on alcohol consumption after the cancer diagnosis to date; their current sociodemographics; functional status (as measured by a patient-reported version of the Eastern Cooperative Oncology Group (ECOG) scale and separately on a 5-point Likert scale from "Poor" to "Excellent");
and self-reported co-morbidities. Clinicopathological data (diagnosis date, disease site, stage, treatments received and treatment intent) were obtained from review of each patient's chart. Given the diversity of cancer subtypes, we grouped all systemic therapies together (hormonal/targeted therapy/chemotherapy/stem cell therapy), and all forms of radiation therapy together (brachytherapy, external beam radiation, radioactive iodine).
| Measurement of alcohol consumption and assessment of patient perceptions
Patients were asked to quantify the number of standard drinks per week with a Canadian guide listing the equivalents of a standard drink based on 13.6 g of ethanol (5 oz wine, 12 oz beer and 1.5 oz liquor; Skinner & Sheu, 1982) . A person who drinks regularly was labelled, "REG," and defined as ever consuming at least 1 drink of alcohol per month in any year of their life; otherwise, they were classified as "NO-REG" (Skinner & Sheu, 1982) . Individuals who drank regularly (REG) were further classified as: "CURRENT REG" if they were consuming alcohol at the time of cancer diagnosis; or "EX-REG" if they were not.
Based on their alcohol consumption status 1 year after diagnosis, CURRENT REG patients were re-classified as having cut down or "DECREASED" if they drank any number of drinks less than they did at diagnosis, or "STOPPED" if they quit entirely. Patients who were EX-REG were re-classified as patients restarting alcohol consumption after diagnosis, or "RESTARTED" if they began to drink alcohol again.
Patients were screened for risk of binge drinking by asking if and when patients had ever consumed more than five (for men) or four (for woman) standard drinks in one day (Canagasaby & Vinson, 2005) .
Using the HBM as a framework, we assessed for patient perceptions on survivorship outcomes as their perceived threat of sequelae. Although patient perceptions on many different survivorship outcomes could be evaluated, we focused on patient perceptions on three different outcomes covering different aspects of cancer survivorship, namely: (a) quality of life, (b) fatigue and (c) 5-year overall survival. We did not a find a previously validated instrument to measure patient perceptions of continued alcohol consumptions on patient outcomes. Hence, we assessed patient perceptions of the harms of continued alcohol consumption after a cancer diagnosis on each of our three outcomes using a 7-point Likert scale (1: makes much worse; 4: no effect; 7: makes much better). We assessed their perceptions on the effect of alcohol on these domains both with respect to their own health and also that of the average cancer patient. Patients were also asked their current thoughts on the harms of continued alcohol consumption on a 5-point Likert scale (1: not harmful, 3: somewhat harmful, 5: very harmful). Additional questions assessed whether patients recalled receiving any information on alcohol consumption after their diagnosis of cancer and who provided the information. This is in keeping with the HBM framework to assess for health recommendations given.
| Statistical analysis
All statistical analyses were conducted using SAS-9.3 and R-v.3.0.2.
Descriptive statistics provided tabulations and summary statistics; comparisons were made using Fisher's exact test, Pearson's chisquare test or Kruskal-Wallis test, where appropriate.
Univariable logistic regression analysis was applied to evaluate the association of each perception, counselling and other socio-demographic and clinicopathological co-variate with their associations of change in alcohol consumption status since diagnosis, in separate analyses of CURRENT REG (outcome: cutting-down or quitting vs.
continuing/increasing consumption) and EX-REG (outcome: restarting consumption after their cancer diagnosis vs. remaining abstinent) in order to identify significant associations. Multivariable logistic regression models were then applied to construct baseline models utilising a backwards selection algorithm with univariable co-variates that were associated with each outcome (p ≤ 0.10) for each analysis.
Each perception or counselling variable was then added individually to this baseline multivariable model and tested for significance using the Wald test. In addition, the effect of multiple negative perceptions together was analysed in the multivariable model using a cumulative index score from 0 to 3 and analysed as 3 vs. 0 to 2. Patients received one point in the index score for each perception they felt alcohol negatively impacted (i.e., quality of life, survival, fatigue) for a maximum of three points.
Sensitivity analysis for the subgroup of patients who were CURRENT REG was conducted where the outcome was defined alternatively as total cessation of alcohol consumption, and in the cancer subtypes that were known to have an association of continued alcohol consumption and worsened survival outcomes, namely lung, head and neck, gastrointestinal and breast cancers (DruesnePecollo et al., 2014; Evangelista et al., 2003; Krebs et al., 2012; Li et al., 2009; Mayne et al., 2009; Thrift et al., 2012) . Correlational analysis between patient perception variables was assessed using the Pearson product-moment correlation coefficient.
| RE SULTS
| Patient recruitment and characteristics
Figure 1 describes the overall recruitment statistics. Of 1,017 patients approached for the study, 187 did not meet inclusion criteria. Overall survey response rate was 61%. Comparing responders to non-responders, there was no significant difference in age, selfrated health or gender (p > 0.05).
From Table 1 , approximately half the patients were female, with mean age of 53 years; the majority were married, English-speaking, received some post-secondary education, worked white collar jobs and were relatively asymptomatic from their malignancy. Most patients had localised disease and had received surgery and/or systemic therapy.
Patients had a broad range of cancers including breast (14%), gastrointestinal (13%), genitourinary-gynaecologic (20%), head and neck (9%), haematologic (21%), lung (9%) and other cancers (13%).
For baseline drinking status, compared to patients who drank regularly at any time in their lifetime (REG), patients who have never drank alcohol regularly (NO-REG) were more likely to be female, non-Caucasian, spoke a language other than English at home, had lower household income, worked white collar jobs, and overall perceived alcohol to be more harmful to both self and the average cancer survivor (Table 1) . Figure 1 describes the baseline alcohol consumption status at the time of diagnosis and subsequently at one year after diagnosis. Using gender-specific guidelines from the Canadian Centre of Substance Abuse (Bondy et al., 1999) , individuals who drank less (DECREASED) or stopped (STOPPED) were also classified into those who drank within recommended guidelines at the time of diagnosis (n = 260, 87% of all patients who were CURRENT REG), and those who exceeded guideline-recommended levels (n = 39, 13%). Among individuals who drank at the time of their diagnosis (CURRENT REG) and within guideline-recommended levels, 32% had quit at one year post-diagnosis, 18% reduced their alcohol intake (any reduction), while 6% increased. Similarly for CURRENT REG individuals who exceeded guideline-recommended levels, 36% quit, 28% reduced intake, and 8% increased intake at one year. 
| Alcohol consumption
| Effect of perceptions of harms of continued drinking and information received on patients who were CURRENT REG
The clinicodemographic variables associated with quitting/reducing alcohol for the overall sample are shown in Supporting Information Table S1 . In Table 2 , after adjustment, perceptions that alcohol worsens the patient's own quality of life, cancer-related fatigue and 5-year overall survival were each significantly associated with a twofold to threefold increase in self-reported reduction in alcohol consumption among cancer patients. These associations remained significant regardless of whether these were perceptions on the effect of alcohol on the patient himself or herself, or perceptions related to the general cancer survivor. Further, all three perceptions were highly correlated (r = 0.70-0.84, p < 0.001, for effect on oneself; r = 0.77-0.89, p < 0.001, for effect on the general cancer survivor). When analysing multiple perceptions together, patients with negative perceptions in all three perceptions were twofold to threefold more likely to reduce or quit drinking when compared to patients with negative perceptions in 0-2 specific perceptions.
Patients who felt that alcohol was overall more harmful were also more likely to reduce their alcohol consumption significantly.
Self-reported recall of having received information or guidance on alcohol cessation from any healthcare provider (or specifically from their oncologist) resulted in more than fourfold to fivefold increases in the chance of quitting/reducing; these factors had a greater magnitude of association with moderating alcohol F I G U R E 1 Summary of recruitment statistics for enrolment into the study and also distribution between patients of who are currently drinking (CURRENT REG), who have stopped drinking (EX-REG) and patients who have never drank regularly (NO-REG) at diagnosis and any change in status at 1-year follow-up (cut down or decreased, continued, quit or stopped, or restarted). *Patients were approached in ambulatory cancer clinics by trained research assistants in a weekly rotating sequential fashion from site to site. The sites recruited from were breast, lung, gastrointestinal, genitourinary, gynaecological, head and neck, haematological, skin/sarcoma clinics. Within each site, patients from all doctors in that clinic were approached and included haematologists/oncologists, radiation oncologists and surgeons consumption than with patient perceptions (Table 2 ). Yet patients who were drinking at diagnosis recalled having received information/counselling from their oncologist only 7% of the time (11% for patients exceeding recommended guidelines; 6% for patients drinking within recommended guidelines).
In sensitivity analysis considering an outcome of total alcohol abstinence at 1 year after diagnosis, perceiving that alcohol negatively impacts each of quality of life, fatigue, survival or on all three domains each remained significantly associated with alcohol cessation, with adjusted ORs ranging from 1.7 to 2.4 (Supporting Information   Table S2 ). Similar results were seen for alcohol counselling with OR (non-significant) trends ranging from 1.6 to 2.3.
In subgroup analysis considering tumour subtypes (gastrointestinal, breast, lung, head and neck) that are known to have a worse outcome with continued alcohol consumption (n = 140), perceiving that alcohol negatively impacts quality of life, fatigue, survival and receiving information/counselling on alcohol moderation each remained significantly associated with a reduction in alcohol consumption, with an exception of perception on the patient's own quality of life which had a non-significant trend in the expected direction (Supporting Information Table S3 ).
Considering patients with excessive drinking by guidelines (n = 39), univariable analysis revealed non-significant trends for patients perceiving alcohol to negatively impact on quality of life, fatigue and overall survival and alcohol moderation, which were in the same direction as our primary analysis (Supporting Information Table S4 ). Among the 17% of patients who did receive information on alcohol moderation, all (100%) such patients either reduced or ceased alcohol consumption 1 year after diagnosis.
Given the limited numbers of cancer survivors who increased their drinking 1 year after diagnosis, exploratory univariable analysis was performed looking for factors associated with increase in alcohol consumption. Patients who had an alcohol binge episode within the last 12 months (OR = 3.71, 95% CI: 1.21-11.40, p = 0.02) were more likely to increase their alcohol consumption after their diagnosis of cancer.
| Effect of perception of harms of continued drinking on patients who were EX-REG
Univariable and multivariable analyses are presented in Supporting Information Table S5 ; not receiving systemic therapy 
| D ISCUSS I ON
Continued alcohol consumption (particularly excessive consumption) after a diagnosis of some cancers has been associated with negative effects on a patient's prognosis and outcome after cancer treatment (Druesne-Pecollo et al., 2014; Evangelista et al., 2003; Mayne et al., 2009; Shih et al., 2012; Thrift et al., 2012) . In this study, negative patient perceptions of continuing to drink alcohol after a diagnosis of cancer on quality of life, fatigue and overall survival were each associated with increased chances of decreased alcohol consumption after a cancer diagnosis. This association was consistent across cancers whereby alcohol is known to negatively affect outcomes and in all cancers in general. Although occurring less than one-sixth of the time, recall of having received counselling on moderating alcohol intake was strongly associated with reducing alcohol consumption, but does not influence relapse rates in patients who were EX-REG at diagnosis. Our results also suggest that patients who currently regularly drink (CURRENT REG) at diagnosis should be counselled regarding the potential harms and effects of continued alcohol consumption on their outcome by a healthcare provider. Anyone with a history of binge drinking should be considered at risk of increasing their alcohol intake after a cancer diagnosis.
One aspect of cancer survivorship involves managing behaviours such as smoking cessation, improving diet and physical activity/weight changes (Demark-Wahnefried, Pinto, & Gritz, 2006) .
Each behaviour has been linked with cancer outcomes, both improved short-term quality of life and improved long-term prognosis (Demark-Wahnefried et al., 2006; Ligibel, 2012; Pinto & Trunzo, 2005 ). Yet, there has been a paucity of studies focused on alcohol consumption in cancer survivors (Ligibel, 2012; Miller et al., 2006; Pinto & Trunzo, 2005) , despite increasing evidence for benefits to prognosis with moderating alcohol intake after a cancer diagnosis (Druesne-Pecollo et al., 2014; Shih et al., 2012; Thrift et al., 2012) .
Studies have also found that alcohol consumption can serve as a barrier to smoking cessation (Hymowitz et al., 1997; Simon, Browner, & Mangano, 1992) .
Multiple theories of health behaviour can explain our results.
Using the HBM as a framework, cancer patients are motivated by their diagnosis of cancer, perceive alcohol to be harmful and with guidance from healthcare providers, change their drinking behaviour accordingly (Rosenstock et al., 1988) . Our findings are also consistent with other models including self-efficacy theory with outcome expectations (Solomon & Annis, 1990) , where cancer patients may judge the consequences of behaviours and adapt their behaviour towards that judgement (Kuther, 2002) . This has predicted drinking behaviour and level of drinking in non-cancer patients and can be applied to cancer influencing alcohol consumption by providing the evidence of consequences of continued drinking. Qualitative studies using focus groups and individual patient interviews will help to determine which of these models or constructs can help to best explain the behaviour changes seen and will likely be required in order to help with developing interventions for alcohol moderation.
The time around diagnosis can be a "teachable moment" for cancer patients with respect to behaviour change including smoking, diet and alcohol consumption (Coa et al., 2015; Demark-Wahnefried et al., 2005; Eng et al., 2014; Frazelle & Friend, 2016; Humpel, Magee, & Jones, 2007; Lawson & Flocke, 2009; McBride, Clipp, Peterson, Lipkus, & Demark-Wahnefried, 2000) . Although this "window of opportunity" allows counselling by healthcare providers (including oncologists), it is infrequently performed (Bradley, Curry, Koepsell, & Larson, 1995; Warnakulasuriya & Johnson, 1999) , despite known successful brief interventions from healthcare providers that require few resources (McIntosh, Leigh, Baldwin, & Marmulak, 1997) . Such strategies hold promise in the cancer setting. Barriers to counselling include lack of standardised and routine screening of alcohol consumption data collection, perceived lack of comfort and training by healthcare providers to counsel alcohol use (Bradley et al., 1995) , and lack of consensus guidelines for cancer patients (Bellizzi, Rowland, Jeffery, & McNeel, 2005) .
There are limitations to our study. First, we focused on the short-term changes in alcohol consumption at 1 year after diagnosis. This short time frame may explain why our relapse rates are very low, though short-term changes are associated with longterm abstinence (Weisner, Ray, Mertens, Satre, & Moore, 2003) .
Longer follow-up may allow for assessment of perception/counselling on survival, treatment response and development of second primary cancers (Demark-Wahnefried et al., 2005) . Second, detailed alcohol use history on our patients who formerly drank regularly (EX-REG) prior to their cancer diagnosis was not collected; we were not able to adjust for this variable in relapse analyses. However, prior studies have found that patients with at-risk drinking behaviours were more likely to relapse, consistent with our multivariable results (Booth, Yates, Petty, & Brown, 1991) . Third, our data assessed patient perceptions rather than knowledge. When assessing for perceptions, we used single-item measures that may not be psychometrically sound and validated measures should be used in future studies to validate these associations. However, our goal was to screen for perceptions and to have these relationships serve as a starting point for additional research. We attempted to reduce effects of social desirability Fourthly, the questionnaire design did not allow us to evaluate whether patients who never drank regularly (NO-REG) started drinking after diagnosis, although this is unlikely to be a major issue. Fifthly, this one-time self-reported questionnaire is prone to reporting selection, social desirability and recall bias, though TA B L E 2 Summary of univariable and multivariable analyses of perception and counselling variables on alcohol cessation or reduction 1 year after diagnosis (vs. no reduction/cessation at 1 year after diagnosis as the reference) 
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